Clinical Trial Update: Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I) [NA]

View source ↗

Summary

Clinical trial PANDA I assessing whether ulinastatin reduces inflammatory response and organ dysfunction after surgery for acute type A aortic dissection; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Syndrome
• Type Aortic Dissection

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Nanjing Medical University | Conditions: Acute Aortic Syndrome, Type a Aortic Dissection | NA | Status: COMPLETED